文献速递腹部介入CTMR

肝细胞癌立体定向体部放疗后的影像学反应:典型影像模式与陷阱

Imaging post-stereotactic body radiation therapy responses for hepatocellular carcinoma: typical imaging patterns and pitfalls.
PubMed 文献 · Abdom Radiol (NY) · 2019-01-01

本文综述肝细胞癌(HCC)接受立体定向体部放疗(SBRT)后的影像学反应特征。与射频消融或经动脉化疗栓塞立即去血管化不同,SBRT后肿瘤反应在影像上需数月才逐渐显现,表现为强化和体积逐渐缩小。识别典型反应模式及非靶肝实质局灶性肝反应至关重要,后者可混淆图像判读。

要点

  • SBRT后肿瘤强化和体积缩小呈数月内逐渐变化,不同于射频消融或TACE的立即去血管化。
  • 非靶肝实质可出现局灶性肝反应,可能混淆对治疗反应的判读。
  • 治疗反应评估影像的时机选择对减少假阴性反应至关重要。

核心结论

  • SBRT后HCC的影像学反应表现多样且随时间逐渐变化,需认识典型反应模式及非靶肝实质局灶性肝反应等可能混淆判读的陷阱,并重视评估影像的时机选择。

研究设计与样本

  • 综述类文章,回顾SBRT后HCC及邻近肝实质的各种影像学特征并讨论影像评估的潜在陷阱;原文未报告检索范围与纳入文献数量。

关键影像表现/征象

  • SBRT后肿瘤反应在影像上表现为强化和体积在数月内逐渐缩小。
  • 非靶肝实质可出现局灶性肝反应,可能混淆图像判读。

临床应用与阅片要点

  • 需认识SBRT后HCC的典型影像反应模式,并注意非靶肝实质局灶性肝反应可能混淆判读。
  • 治疗反应评估影像的时机选择对减少假阴性反应至关重要。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Stereotactic body radiation therapy (SBRT) has increased utility in the management of hepatocellular carcinoma (HCC) ranging from local therapy in early-stage HCC not suitable for other focal therapies to end-stage HCC. As the indications for the use of SBRT in HCC expand, diagnostic imaging is being increasingly used to assess response to treatment. The imaging features of tumor response do not parallel those of other focal therapies such as radiofrequency ablation or trans-arterial chemoembolization that immediately devascularize the tumor. The tumor response to SBRT on imaging takes much longer and often shows gradual changes including the reduction of enhancement and size over several months. It is essential to recognize the typical imaging patterns of response, as well as the appearance of focal liver reaction in the non-target liver that can confound image interpretation. The timing of treatment response assessment imaging is fundamental to minimize the potential for false negative response. The purpose of this article is to review the variable post-SBRT imaging features of HCC and adjacent liver parenchyma and discuss the potential pitfalls of imaging evaluation after SBRT for HCC.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Mastrocostas K, Jang HJ, Fischer S, et al. Imaging post-stereotactic body radiation therapy responses for hepatocellular carcinoma: typical imaging patterns and pitfalls. Abdom Radiol (NY). 2019. PMID: 30710166. doi:10.1007/s00261-019-01901-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。